Determining therapeutic trough ranges for linezolid

Linezolid (LZD) is an oxazolidinone approved for the treatment of gram-positive infections. Therapeutic drug monitoring is increasingly used to optimize LZD dosing. The therapeutic target for LZD is to achieve an area under the concentration-time curve over 24 h divided by the MIC (AUC/MIC) > 100...

Descripción completa

Detalles Bibliográficos
Autor principal: Alsultan, Abdullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921164/
https://www.ncbi.nlm.nih.gov/pubmed/31885465
http://dx.doi.org/10.1016/j.jsps.2019.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921164/
https://www.ncbi.nlm.nih.gov/pubmed/31885465
http://dx.doi.org/10.1016/j.jsps.2019.09.002

Ejemplares similares